Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab?

Hillner BE, Smith TJ. Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab? J Clin Oncol. 2007 Feb 20; 25(6):611-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.